In this second part of a 2-part series on the global burden of cardiovascular disease, we
review the proven, effective approaches to the prevention and treatment of cardiovascular …

Coronary heart disease is a chronic, systemic disease with a wide range of associated
symptoms, clinical outcomes, and health care expenditure. Adverse events from coronary …

Background Cardiovascular clinical trials have traditionally incorporated separate time-to-
first-event analyses for their primary efficacy and safety comparisons, but this framework has …

Angina is the main symptom of ischemic heart disease; mirroring a mismatch between
oxygen supply and demand. Epicardial coronary stenoses are only responsible for nearly …

血小板在血栓形成过程中发挥着重要的作用. 作用于血小板黏附, 聚集等过程的抗血小板药物能
有效地抑制体内血栓形成, 预防和治疗急性冠脉综合征和缺血性脑卒中, 抑制动脉粥样斑块破裂 …

Coronary artery disease exhibits growing mortality and morbidity worldwide despite the
advances in pharmacotherapy and coronary intervention. Coronary artery disease is …

Coronary artery disease is a leading cause of morbidity and mortality worldwide. Acute
coronary syndrome as a first presentation is common and patients with established disease …

Background Gastrointestinal bleeding (GIB) frequently occurs following percutaneous
coronary intervention (PCI) for acute coronary syndrome (ACS) with the prescription of …

Patients with previous myocardial infarction (MI) are at high risk of recurrent MI, stroke, and
cardiovascular death, with a 5-year risk of nearly 40%. Although the highest risk period is …

The discovery of the role of platelets in cardiovascular disease led to the introduction of
aspirin as a therapeutic agent for heart disease. Aspirin has proven to be effective in …